Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study.
Hawra Ali Hussain AlsayedFatemeh Saheb Sharif-AskariNarjes Saheb Sharif-AskariAli Al Sayed HussainQutayba HamidRabih HalwaniPublished in: PloS one (2021)
Early administration of remdesivir within 7 days of symptom onset is associated with less need for mechanical ventilation and lower 28-days mortality.